224 related articles for article (PubMed ID: 1452354)
1. Streptococcal C5a peptidase is a highly specific endopeptidase.
Cleary PP; Prahbu U; Dale JB; Wexler DE; Handley J
Infect Immun; 1992 Dec; 60(12):5219-23. PubMed ID: 1452354
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the streptococcal C5a peptidase using a C5a-green fluorescent protein fusion protein substrate.
Stafslien DK; Cleary PP
J Bacteriol; 2000 Jun; 182(11):3254-8. PubMed ID: 10809707
[TBL] [Abstract][Full Text] [Related]
3. Model for substrate interactions in C5a peptidase from Streptococcus pyogenes: A 1.9 A crystal structure of the active form of ScpA.
Kagawa TF; O'Connell MR; Mouat P; Paoli M; O'Toole PW; Cooney JC
J Mol Biol; 2009 Feb; 386(3):754-72. PubMed ID: 19152799
[TBL] [Abstract][Full Text] [Related]
4. In vivo Streptococcus pyogenes C5a peptidase activity: analysis using transposon- and nitrosoguanidine-induced mutants.
O'Connor SP; Cleary PP
J Infect Dis; 1987 Sep; 156(3):495-504. PubMed ID: 3039012
[TBL] [Abstract][Full Text] [Related]
5. Cleavage of the human C5A receptor by proteinases derived from Porphyromonas gingivalis: cleavage of leukocyte C5a receptor.
Jagels MA; Ember JA; Travis J; Potempa J; Pike R; Hugli TE
Adv Exp Med Biol; 1996; 389():155-64. PubMed ID: 8861006
[TBL] [Abstract][Full Text] [Related]
6. Conservation of the C5a peptidase genes in group A and B streptococci.
Chmouryguina I; Suvorov A; Ferrieri P; Cleary PP
Infect Immun; 1996 Jul; 64(7):2387-90. PubMed ID: 8698456
[TBL] [Abstract][Full Text] [Related]
7. Multi-functional mechanisms of immune evasion by the streptococcal complement inhibitor C5a peptidase.
Lynskey NN; Reglinski M; Calay D; Siggins MK; Mason JC; Botto M; Sriskandan S
PLoS Pathog; 2017 Aug; 13(8):e1006493. PubMed ID: 28806402
[TBL] [Abstract][Full Text] [Related]
8. C5a peptidase alters clearance and trafficking of group A streptococci by infected mice.
Ji Y; McLandsborough L; Kondagunta A; Cleary PP
Infect Immun; 1996 Feb; 64(2):503-10. PubMed ID: 8550199
[TBL] [Abstract][Full Text] [Related]
9. Processing, stability, and kinetic parameters of C5a peptidase from Streptococcus pyogenes.
Anderson ET; Wetherell MG; Winter LA; Olmsted SB; Cleary PP; Matsuka YV
Eur J Biochem; 2002 Oct; 269(19):4839-51. PubMed ID: 12354115
[TBL] [Abstract][Full Text] [Related]
10. Similarity between the group B and A streptococcal C5a peptidase genes.
Cleary PP; Handley J; Suvorov AN; Podbielski A; Ferrieri P
Infect Immun; 1992 Oct; 60(10):4239-44. PubMed ID: 1398935
[TBL] [Abstract][Full Text] [Related]
11. Structural heterogeneity of the streptococcal C5a peptidase gene in Streptococcus pyogenes.
Koroleva IV; Efstratiou A; Suvorov AN
J Bacteriol; 2002 Nov; 184(22):6384-6. PubMed ID: 12399509
[TBL] [Abstract][Full Text] [Related]
12. Human immunogenicity studies on group A streptococcal C5a peptidase (SCPA) as a potential vaccine against group A streptococcal infections.
Shet A; Kaplan E; Johnson D; Cleary PP
Indian J Med Res; 2004 May; 119 Suppl():95-8. PubMed ID: 15232171
[TBL] [Abstract][Full Text] [Related]
13. Complete nucleotide sequence of the streptococcal C5a peptidase gene of Streptococcus pyogenes.
Chen CC; Cleary PP
J Biol Chem; 1990 Feb; 265(6):3161-7. PubMed ID: 2406246
[TBL] [Abstract][Full Text] [Related]
14. Localization of the streptococcal C5a peptidase to the surface of group A streptococci.
O'Connor SP; Cleary PP
Infect Immun; 1986 Aug; 53(2):432-4. PubMed ID: 3525415
[TBL] [Abstract][Full Text] [Related]
15. The 1.7 Å crystal structure of the C5a peptidase from Streptococcus agalactiae (ScpB) reveals an active site competent for catalysis.
Cullen R; Teçza M; Miclot T; Behan S; Jain M; Avink MK; Cooney JC; Kagawa TF
Proteins; 2024 Mar; 92(3):427-431. PubMed ID: 37921533
[TBL] [Abstract][Full Text] [Related]
16. Multifunctional glyceraldehyde-3-phosphate dehydrogenase of Streptococcus pyogenes is essential for evasion from neutrophils.
Terao Y; Yamaguchi M; Hamada S; Kawabata S
J Biol Chem; 2006 May; 281(20):14215-23. PubMed ID: 16565520
[TBL] [Abstract][Full Text] [Related]
17. Active and passive intranasal immunizations with streptococcal surface protein C5a peptidase prevent infection of murine nasal mucosa-associated lymphoid tissue, a functional homologue of human tonsils.
Park HS; Cleary PP
Infect Immun; 2005 Dec; 73(12):7878-86. PubMed ID: 16299278
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of genes in the vir regulon of Streptococcus pyogenes is controlled by transcription termination.
Pritchard KH; Cleary PP
Mol Gen Genet; 1996 Feb; 250(2):207-13. PubMed ID: 8628220
[TBL] [Abstract][Full Text] [Related]
19. Virulent human strains of group G streptococci express a C5a peptidase enzyme similar to that produced by group A streptococci.
Cleary PP; Peterson J; Chen C; Nelson C
Infect Immun; 1991 Jul; 59(7):2305-10. PubMed ID: 2050400
[TBL] [Abstract][Full Text] [Related]
20. Immune response to group A streptococcal C5a peptidase in children: implications for vaccine development.
Shet A; Kaplan EL; Johnson DR; Cleary PP
J Infect Dis; 2003 Sep; 188(6):809-17. PubMed ID: 12964111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
